Insights into protein kinase regulation and inhibition by large scale structural comparison. by Eswaran, J, Knapp, S

Targeting group II PAKs in cancer and metastasis. by Eswaran, J, Soundararajan, M, Knapp, S

Targeting group II PAKs in cancer and metastasis. by Eswaran, J, Soundararajan, M, Knapp, S

UnPAKing the class differences among p21-activated kinases. by Eswaran, J, Soundararajan, M, Kumar, R, Knapp, S

Crystal structure of human protein tyrosine phosphatase 14 (PTPN14) at 1.65-A resolution. by Barr, A, Debreczeni, J, Eswaran, J, Knapp, S

Crystal structure of human protein tyrosine phosphatase 14 (PTPN14) at 1.65-A resolution. by Barr, A, Debreczeni, J, Eswaran, J, Knapp, S

The crystal structure of human receptor protein tyrosine phosphatase kappa phosphatase domain 1. by Eswaran, J, Debreczeni, J, Longman, E, Barr, A, Knapp, S

Structure of the pseudokinase VRK3 reveals a degraded catalytic site, a highly conserved kinase fold, and a putative regulatory binding site. by Scheeff, E, Eswaran, J, Bunkoczi, G, Knapp, S, Manning, G

Structure of the pseudokinase VRK3 reveals a degraded catalytic site, a highly conserved kinase fold, and a putative regulatory binding site. by Scheeff, E, Eswaran, J, Bunkoczi, G, Knapp, S, Manning, G

Three's company: component structures bring a closer view of tripartite drug efflux pumps. by Eswaran, J, Koronakis, E, Higgins, M, Hughes, C, Koronakis, V

Structure of the ligand-blocked periplasmic entrance of the bacterial multidrug efflux protein TolC. by Higgins, M, Eswaran, J, Edwards, P, Schertler, G, Hughes, C, Koronakis, V

Structure and functional characterization of the atypical human kinase haspin. by Eswaran, J, Patnaik, D, Filippakopoulos, P, Wang, F, Stein, R, Murray, J, Higgins, J, Knapp, S

Structure and functional characterization of the atypical human kinase haspin. by Eswaran, J, Patnaik, D, Filippakopoulos, P, Wang, F, Stein, R, Murray, J, Higgins, J, Knapp, S

Crystal Structures of the p21-activated kinases PAK4, PAK5, and PAK6 reveal catalytic domain plasticity of active group II PAKs by Eswaran, J, Lee, W, Debreczeni, J, Filippakopoulos, P, Turnbull, A, Fedorov, O, Deacon, S, Peterson, J, Knapp, S

Crystal Structures of the p21-activated kinases PAK4, PAK5, and PAK6 reveal catalytic domain plasticity of active group II PAKs. by Eswaran, J, Lee, W, Debreczeni, J, Filippakopoulos, P, Turnbull, A, Fedorov, O, Deacon, S, Peterson, JR, Knapp, S

Structures of Down syndrome kinases, DYRKs, reveal mechanisms of kinase activation and substrate recognition. by Soundararajan, M, Roos, A, Savitsky, P, Filippakopoulos, P, Kettenbach, A, Olsen, J, Gerber, SA, Eswaran, J, Knapp, S, Elkins, J

Structures of down syndrome kinases, DYRKs, reveal mechanisms of kinase activation and substrate recognition by Soundararajan, M, Roos, A, Savitsky, P, Filippakopoulos, P, Eswaran, J, Knapp, S, Elkins, J, Kettenbach, A, Gerber, SA, Olsen, J

Structure of the human protein kinase MPSK1 reveals an atypical activation loop architecture. by Eswaran, J, Bernad, A, Ligos, J, Guinea, B, Debreczeni, J, Sobott, F, Parker, SA, Najmanovich, R, Turk, B, Knapp, S

Crystal structures and inhibitor identification for PTPN5, PTPRR and PTPN7: a family of human MAPK-specific protein tyrosine phosphatases. by Eswaran, J, von Kries, J, Marsden, B, Longman, E, Debreczeni, J, Ugochukwu, E, Turnbull, A, Lee, W, Knapp, S, Barr, A